Aster DM Healthcare , a prominent healthcare provider, has received approval to shift its registered office from Karnataka to Telangana, marking a significant corporate move. The Regional Director (South East Region) of the Ministry of Corporate Affairs granted the approval on November 18, 2025, allowing the company to relocate its base to Hyderabad.

Key Details of the Relocation

Reasons for Relocation

Aster DM Healthcare cited several strategic reasons for this move:

1. Better administrative convenience
2. Improved operational efficiency
3. Enhanced business integration
4. Seamless implementation of company schemes

Regulatory Compliance

The company has stated that it is in the process of making necessary intimations and filings with the Registrar of Companies and other statutory authorities, as required by law. This move also entails a consequent alteration in the company's Memorandum of Association to reflect the change in registered office location.

Next Steps

Following this approval, Aster DM Healthcare is expected to complete the relocation process and update all relevant stakeholders, including shareholders, regulatory bodies, and business partners, about the change in its registered office address.

This strategic relocation underscores Aster DM Healthcare's commitment to optimizing its operations and potentially signals a focus on expanding its presence in the Telangana region.

Aster DM Healthcare , a leading healthcare provider, has reported a robust financial performance for the second quarter of fiscal year 2026 (Q2FY26), with significant growth in revenue and profitability. The company's strategic focus on high-value care and operational efficiency has yielded positive results across its key markets.

Financial Highlights

Operational Performance

• Kerala Cluster: Achieved record quarterly revenue of ₹620.00 Crore, growing 11% YoY
• Karnataka & Maharashtra: Reported 10% YoY revenue growth
• Andhra Pradesh & Telangana: Revenue grew 8% YoY

Key Growth Drivers

1. Specialty Mix Improvement:

   • Oncology revenue grew by 26% YoY, now contributing 11% to total revenue
   • CONGO-T (Cardiology, Oncology, Neurosciences, Gastroenterology, and Orthopedics) specialties showed strong performance

2. Medical Value Travel (MVT):

   • MVT segment grew 60% QoQ and 26% YoY
   • Kerala cluster's MVT business grew by 67%, particularly from Maldives, Middle East, and North African countries

3. Operational Efficiency:

   • Average Length of Stay (ALOS) reduced to 3.1 days from 3.2-3.3 days
   • Enhanced cost control and clinical efficiency across the network

4. Payor Mix Optimization:

   • Increased focus on cash and insurance patients

Expansion and Future Outlook

Aster DM Healthcare continues to expand its footprint and enhance its capabilities:

• Added over 200 beds in the past year, bringing total capacity to 5,199 beds
• Commissioned a new 264-bed hospital in Kasaragod, Kerala on October 2, 2025
• Plans to add another 2,300+ beds through greenfield and brownfield projects in the coming years

The company is also progressing with its merger with Quality Care India Limited, which is expected to create a combined entity with 38 hospitals across 27 cities and over 10,360 beds.

Management Commentary

Alisha Moopen, Deputy Managing Director, stated, "Q2 FY26 has been a period of meaningful progress for Aster, marked by steady financial performance, recovery in a key market i.e. Kerala, and continued advancement of our long-term strategic priorities."

Ramesh Kumar, Chief Operating Officer, highlighted the strong performance of the Kerala cluster, noting, "The improvement was driven primarily by a richer specialty mix, and a 5% YoY increase in ARPP (IP), supported by higher contribution from complex procedures and MVT business growth."

Sunil Kumar, Chief Financial Officer, commented on the margin improvement, saying, "Despite lower incidence of vector-borne diseases - which typically carry higher margins - I'm pleased to share that our Operating EBITDA improved by 13% YoY."

Aster DM Healthcare's Q2 FY26 results demonstrate the company's resilience and ability to deliver consistent growth. With its focus on expanding high-value care services, operational efficiency, and strategic expansion, the company is well-positioned for sustainable growth in the coming quarters.